ABCG2 and neoplasm: One study has found that resistance to DOX therapy fails to eradicate anaplastic thyroid cancer or even to stop tumor progress was closely related to adenosine triphosphate-binding cassette subfamily G member 2 (ABCG2) (Zheng et al. 2010).